Ken Emond from the British Academy will again be returning to BU on Tuesday the 6th March 2018. Don’t forget to get yourself booked in!
This is an invaluable opportunity to find out more about the international and domestic funding available through the organisation. For those of you who are not familiar with the British Academy, it is the UK’s leading independent body for the humanities and social sciences, promoting funding, knowledge exchange and providing independent advice within the humanities.
The session will last just over 1 hour (12:30pm-13:30pm) and will comprise a presentation focusing on international and domestic funding opportunities along with an overview of the British Academy and any recent developments, followed by a Q&A session.
Representatives of the British Academy will be available to answer any individual queries not covered in the presentation or Q&A session, and members of the Research and Knowledge Exchange Office will be on hand should you wish to discuss BU’s processes for bidding to the organisation.
Places for this event can be reserved through Organisational Development here
British Academy Visit – reserve your place now!










BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
UKCGE Recognised Research Supervision Programme: Final Deadline Reminder
The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease